Global Natural Killer (NK) Cell Therapeutics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
LPI (LP Information)' newest research report, the “Natural Killer (NK) Cell Therapeutics Industry Forecast” looks at past sales and reviews total world Natural Killer (NK) Cell Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Natural Killer (NK) Cell Therapeutics sales for 2023 through 2029. With Natural Killer (NK) Cell Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer (NK) Cell Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Natural Killer (NK) Cell Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natural Killer (NK) Cell Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer (NK) Cell Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer (NK) Cell Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer (NK) Cell Therapeutics.
The global Natural Killer (NK) Cell Therapeutics market size is projected to grow from US$ 250.2 million in 2022 to US$ 319 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer (NK) Cell Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
LPI (LP Information)' newest research report, the “Natural Killer (NK) Cell Therapeutics Industry Forecast” looks at past sales and reviews total world Natural Killer (NK) Cell Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Natural Killer (NK) Cell Therapeutics sales for 2023 through 2029. With Natural Killer (NK) Cell Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer (NK) Cell Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Natural Killer (NK) Cell Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natural Killer (NK) Cell Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer (NK) Cell Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer (NK) Cell Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer (NK) Cell Therapeutics.
The global Natural Killer (NK) Cell Therapeutics market size is projected to grow from US$ 250.2 million in 2022 to US$ 319 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer (NK) Cell Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Mogamulizumab
- Lorvotuzumab Mertansine
- Others
- Cancer
- Cardiovascular Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chipscreen Biosciences
- Affimed NV
- Altor BioScience
- Innate Pharma
- Takeda
- Sorrento Therapeutics
- NantKwest
- Bristol-Myers Squibb
- NKT
- Henry Ford Health Services
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size 2018-2029
2.1.2 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Natural Killer (NK) Cell Therapeutics Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 Natural Killer (NK) Cell Therapeutics Market Size by Type
2.3.1 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Natural Killer (NK) Cell Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 Natural Killer (NK) Cell Therapeutics Market Size by Application
2.5.1 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
3 NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Natural Killer (NK) Cell Therapeutics Market Size Market Share by Players
3.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Natural Killer (NK) Cell Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NATURAL KILLER (NK) CELL THERAPEUTICS BY REGIONS
4.1 Natural Killer (NK) Cell Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
4.3 APAC Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
4.4 Europe Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023)
5.2 Americas Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
5.3 Americas Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023)
6.2 APAC Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
6.3 APAC Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Natural Killer (NK) Cell Therapeutics by Country (2018-2023)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET FORECAST
10.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Natural Killer (NK) Cell Therapeutics Forecast
10.1.3 APAC Natural Killer (NK) Cell Therapeutics Forecast
10.1.4 Europe Natural Killer (NK) Cell Therapeutics Forecast
10.1.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Forecast
10.2 Americas Natural Killer (NK) Cell Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Natural Killer (NK) Cell Therapeutics Market Forecast
10.2.2 Canada Natural Killer (NK) Cell Therapeutics Market Forecast
10.2.3 Mexico Natural Killer (NK) Cell Therapeutics Market Forecast
10.2.4 Brazil Natural Killer (NK) Cell Therapeutics Market Forecast
10.3 APAC Natural Killer (NK) Cell Therapeutics Forecast by Region (2024-2029)
10.3.1 China Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.2 Japan Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.3 Korea Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.4 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.5 India Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.6 Australia Natural Killer (NK) Cell Therapeutics Market Forecast
10.4 Europe Natural Killer (NK) Cell Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.2 France Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.3 UK Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.4 Italy Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.5 Russia Natural Killer (NK) Cell Therapeutics Market Forecast
10.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.2 South Africa Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.3 Israel Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.4 Turkey Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.5 GCC Countries Natural Killer (NK) Cell Therapeutics Market Forecast
10.6 Global Natural Killer (NK) Cell Therapeutics Forecast by Type (2024-2029)
10.7 Global Natural Killer (NK) Cell Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Information
11.1.2 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offered
11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Chipscreen Biosciences Main Business Overview
11.1.5 Chipscreen Biosciences Latest Developments
11.2 Affimed NV
11.2.1 Affimed NV Company Information
11.2.2 Affimed NV Natural Killer (NK) Cell Therapeutics Product Offered
11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Affimed NV Main Business Overview
11.2.5 Affimed NV Latest Developments
11.3 Altor BioScience
11.3.1 Altor BioScience Company Information
11.3.2 Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offered
11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Altor BioScience Main Business Overview
11.3.5 Altor BioScience Latest Developments
11.4 Innate Pharma
11.4.1 Innate Pharma Company Information
11.4.2 Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offered
11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Innate Pharma Main Business Overview
11.4.5 Innate Pharma Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Natural Killer (NK) Cell Therapeutics Product Offered
11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Information
11.6.2 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offered
11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sorrento Therapeutics Main Business Overview
11.6.5 Sorrento Therapeutics Latest Developments
11.7 NantKwest
11.7.1 NantKwest Company Information
11.7.2 NantKwest Natural Killer (NK) Cell Therapeutics Product Offered
11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NantKwest Main Business Overview
11.7.5 NantKwest Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offered
11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 NKT
11.9.1 NKT Company Information
11.9.2 NKT Natural Killer (NK) Cell Therapeutics Product Offered
11.9.3 NKT Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 NKT Main Business Overview
11.9.5 NKT Latest Developments
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Information
11.10.2 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offered
11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Henry Ford Health Services Main Business Overview
11.10.5 Henry Ford Health Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size 2018-2029
2.1.2 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Natural Killer (NK) Cell Therapeutics Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 Natural Killer (NK) Cell Therapeutics Market Size by Type
2.3.1 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Natural Killer (NK) Cell Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 Natural Killer (NK) Cell Therapeutics Market Size by Application
2.5.1 Natural Killer (NK) Cell Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
3 NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Natural Killer (NK) Cell Therapeutics Market Size Market Share by Players
3.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Natural Killer (NK) Cell Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NATURAL KILLER (NK) CELL THERAPEUTICS BY REGIONS
4.1 Natural Killer (NK) Cell Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
4.3 APAC Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
4.4 Europe Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023)
5.2 Americas Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
5.3 Americas Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023)
6.2 APAC Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
6.3 APAC Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Natural Killer (NK) Cell Therapeutics by Country (2018-2023)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET FORECAST
10.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Natural Killer (NK) Cell Therapeutics Forecast
10.1.3 APAC Natural Killer (NK) Cell Therapeutics Forecast
10.1.4 Europe Natural Killer (NK) Cell Therapeutics Forecast
10.1.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Forecast
10.2 Americas Natural Killer (NK) Cell Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Natural Killer (NK) Cell Therapeutics Market Forecast
10.2.2 Canada Natural Killer (NK) Cell Therapeutics Market Forecast
10.2.3 Mexico Natural Killer (NK) Cell Therapeutics Market Forecast
10.2.4 Brazil Natural Killer (NK) Cell Therapeutics Market Forecast
10.3 APAC Natural Killer (NK) Cell Therapeutics Forecast by Region (2024-2029)
10.3.1 China Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.2 Japan Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.3 Korea Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.4 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.5 India Natural Killer (NK) Cell Therapeutics Market Forecast
10.3.6 Australia Natural Killer (NK) Cell Therapeutics Market Forecast
10.4 Europe Natural Killer (NK) Cell Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.2 France Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.3 UK Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.4 Italy Natural Killer (NK) Cell Therapeutics Market Forecast
10.4.5 Russia Natural Killer (NK) Cell Therapeutics Market Forecast
10.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.2 South Africa Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.3 Israel Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.4 Turkey Natural Killer (NK) Cell Therapeutics Market Forecast
10.5.5 GCC Countries Natural Killer (NK) Cell Therapeutics Market Forecast
10.6 Global Natural Killer (NK) Cell Therapeutics Forecast by Type (2024-2029)
10.7 Global Natural Killer (NK) Cell Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Information
11.1.2 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offered
11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Chipscreen Biosciences Main Business Overview
11.1.5 Chipscreen Biosciences Latest Developments
11.2 Affimed NV
11.2.1 Affimed NV Company Information
11.2.2 Affimed NV Natural Killer (NK) Cell Therapeutics Product Offered
11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Affimed NV Main Business Overview
11.2.5 Affimed NV Latest Developments
11.3 Altor BioScience
11.3.1 Altor BioScience Company Information
11.3.2 Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offered
11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Altor BioScience Main Business Overview
11.3.5 Altor BioScience Latest Developments
11.4 Innate Pharma
11.4.1 Innate Pharma Company Information
11.4.2 Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offered
11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Innate Pharma Main Business Overview
11.4.5 Innate Pharma Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Natural Killer (NK) Cell Therapeutics Product Offered
11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Information
11.6.2 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offered
11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sorrento Therapeutics Main Business Overview
11.6.5 Sorrento Therapeutics Latest Developments
11.7 NantKwest
11.7.1 NantKwest Company Information
11.7.2 NantKwest Natural Killer (NK) Cell Therapeutics Product Offered
11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NantKwest Main Business Overview
11.7.5 NantKwest Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offered
11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 NKT
11.9.1 NKT Company Information
11.9.2 NKT Natural Killer (NK) Cell Therapeutics Product Offered
11.9.3 NKT Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 NKT Main Business Overview
11.9.5 NKT Latest Developments
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Information
11.10.2 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offered
11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Henry Ford Health Services Main Business Overview
11.10.5 Henry Ford Health Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Mogamulizumab
Table 3. Major Players of Lorvotuzumab Mertansine
Table 4. Major Players of Others
Table 5. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Natural Killer (NK) Cell Therapeutics Key Players Head office and Products Offered
Table 14. Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Natural Killer (NK) Cell Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Natural Killer (NK) Cell Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Natural Killer (NK) Cell Therapeutics
Table 46. Key Market Challenges & Risks of Natural Killer (NK) Cell Therapeutics
Table 47. Key Industry Trends of Natural Killer (NK) Cell Therapeutics
Table 48. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Chipscreen Biosciences Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 53. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offered
Table 54. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Chipscreen Biosciences Main Business
Table 56. Chipscreen Biosciences Latest Developments
Table 57. Affimed NV Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 58. Affimed NV Natural Killer (NK) Cell Therapeutics Product Offered
Table 59. Affimed NV Main Business
Table 60. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Affimed NV Latest Developments
Table 62. Altor BioScience Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 63. Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offered
Table 64. Altor BioScience Main Business
Table 65. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Altor BioScience Latest Developments
Table 67. Innate Pharma Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 68. Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offered
Table 69. Innate Pharma Main Business
Table 70. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Innate Pharma Latest Developments
Table 72. Takeda Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 73. Takeda Natural Killer (NK) Cell Therapeutics Product Offered
Table 74. Takeda Main Business
Table 75. Takeda Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Takeda Latest Developments
Table 77. Sorrento Therapeutics Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 78. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offered
Table 79. Sorrento Therapeutics Main Business
Table 80. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sorrento Therapeutics Latest Developments
Table 82. NantKwest Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 83. NantKwest Natural Killer (NK) Cell Therapeutics Product Offered
Table 84. NantKwest Main Business
Table 85. NantKwest Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NantKwest Latest Developments
Table 87. Bristol-Myers Squibb Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 88. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offered
Table 89. Bristol-Myers Squibb Main Business
Table 90. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Bristol-Myers Squibb Latest Developments
Table 92. NKT Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 93. NKT Natural Killer (NK) Cell Therapeutics Product Offered
Table 94. NKT Main Business
Table 95. NKT Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. NKT Latest Developments
Table 97. Henry Ford Health Services Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 98. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offered
Table 99. Henry Ford Health Services Main Business
Table 100. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Henry Ford Health Services Latest Developments
Table 1. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Mogamulizumab
Table 3. Major Players of Lorvotuzumab Mertansine
Table 4. Major Players of Others
Table 5. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Natural Killer (NK) Cell Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Natural Killer (NK) Cell Therapeutics Key Players Head office and Products Offered
Table 14. Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Natural Killer (NK) Cell Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Natural Killer (NK) Cell Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Natural Killer (NK) Cell Therapeutics
Table 46. Key Market Challenges & Risks of Natural Killer (NK) Cell Therapeutics
Table 47. Key Industry Trends of Natural Killer (NK) Cell Therapeutics
Table 48. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Chipscreen Biosciences Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 53. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offered
Table 54. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Chipscreen Biosciences Main Business
Table 56. Chipscreen Biosciences Latest Developments
Table 57. Affimed NV Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 58. Affimed NV Natural Killer (NK) Cell Therapeutics Product Offered
Table 59. Affimed NV Main Business
Table 60. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Affimed NV Latest Developments
Table 62. Altor BioScience Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 63. Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offered
Table 64. Altor BioScience Main Business
Table 65. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Altor BioScience Latest Developments
Table 67. Innate Pharma Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 68. Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offered
Table 69. Innate Pharma Main Business
Table 70. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Innate Pharma Latest Developments
Table 72. Takeda Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 73. Takeda Natural Killer (NK) Cell Therapeutics Product Offered
Table 74. Takeda Main Business
Table 75. Takeda Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Takeda Latest Developments
Table 77. Sorrento Therapeutics Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 78. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offered
Table 79. Sorrento Therapeutics Main Business
Table 80. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sorrento Therapeutics Latest Developments
Table 82. NantKwest Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 83. NantKwest Natural Killer (NK) Cell Therapeutics Product Offered
Table 84. NantKwest Main Business
Table 85. NantKwest Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NantKwest Latest Developments
Table 87. Bristol-Myers Squibb Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 88. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offered
Table 89. Bristol-Myers Squibb Main Business
Table 90. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Bristol-Myers Squibb Latest Developments
Table 92. NKT Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 93. NKT Natural Killer (NK) Cell Therapeutics Product Offered
Table 94. NKT Main Business
Table 95. NKT Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. NKT Latest Developments
Table 97. Henry Ford Health Services Details, Company Type, Natural Killer (NK) Cell Therapeutics Area Served and Its Competitors
Table 98. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offered
Table 99. Henry Ford Health Services Main Business
Table 100. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Henry Ford Health Services Latest Developments
LIST OF FIGURES
Figure 1. Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Natural Killer (NK) Cell Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Natural Killer (NK) Cell Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Natural Killer (NK) Cell Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type in 2022
Figure 10. Natural Killer (NK) Cell Therapeutics in Cancer
Figure 11. Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Natural Killer (NK) Cell Therapeutics in Cardiovascular Diseases
Figure 13. Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 14. Natural Killer (NK) Cell Therapeutics in Others
Figure 15. Global Natural Killer (NK) Cell Therapeutics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application in 2022
Figure 17. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player in 2022
Figure 18. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Country in 2022
Figure 24. United States Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region in 2022
Figure 29. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type in 2022
Figure 30. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application in 2022
Figure 31. China Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country in 2022
Figure 38. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. United States Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. China Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. India Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. France Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. UK Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Natural Killer (NK) Cell Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Natural Killer (NK) Cell Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Natural Killer (NK) Cell Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type in 2022
Figure 10. Natural Killer (NK) Cell Therapeutics in Cancer
Figure 11. Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Natural Killer (NK) Cell Therapeutics in Cardiovascular Diseases
Figure 13. Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 14. Natural Killer (NK) Cell Therapeutics in Others
Figure 15. Global Natural Killer (NK) Cell Therapeutics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application in 2022
Figure 17. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Player in 2022
Figure 18. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Country in 2022
Figure 24. United States Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region in 2022
Figure 29. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type in 2022
Figure 30. APAC Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application in 2022
Figure 31. China Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Country in 2022
Figure 38. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Natural Killer (NK) Cell Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. United States Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. China Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. India Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. France Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. UK Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Natural Killer (NK) Cell Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Natural Killer (NK) Cell Therapeutics Market Size Market Share Forecast by Application (2024-2029)
